Weekend Biotech Reading List

FDA’s Pazdur Calls Accelerated Approval An “Interim Decision” With Ariad In Mind $ARIA
Ramsey Baghdadi (Elsevier Business Intelligence)

Compassionate Access: No Good Answer
Derek Lowe (In the Pipeline)

'Master Protocol' Could Revolutionalize Trials in  Lung Cancer, and Eventually Other Cancers
Caroline Helwick (The ASCO Post)
With New Study, Scientists Try To Drag Drug Trials Into DNA Age
Matthew Herper (Forbes)

How I Use Twitter
Dale Yuzuki (Next Generation Technologist)

BIOSIMILARS TAKE CENTRE STAGE AT ACR 2013
Biosimilarz Blog

Science Being Studied: Replication, Publication, And Resource Allocation
Bruce Booth (LifeSciVC)